These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 23142434)
1. Renin-angiotensin system blockers affect cognitive decline and serum adipocytokines in Alzheimer's disease. Furiya Y; Ryo M; Kawahara M; Kiriyama T; Morikawa M; Ueno S Alzheimers Dement; 2013 Sep; 9(5):512-8. PubMed ID: 23142434 [TBL] [Abstract][Full Text] [Related]
2. Impact of renin-angiotensin system-targeting antihypertensive drugs on treatment of Alzheimer's disease: a meta-analysis. Ye R; Hu Y; Yao A; Yang Y; Shi Y; Jiang Y; Zhang J Int J Clin Pract; 2015 Jun; 69(6):674-81. PubMed ID: 25721930 [TBL] [Abstract][Full Text] [Related]
3. Modulation of Renin-Angiotensin System May Slow Conversion from Mild Cognitive Impairment to Alzheimer's Disease. Wharton W; Goldstein FC; Zhao L; Steenland K; Levey AI; Hajjar I J Am Geriatr Soc; 2015 Sep; 63(9):1749-56. PubMed ID: 26389987 [TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease is associated with a low prevalence of hypertension. Kuyumcu ME; Yesil Y; Oztürk ZA; Halil M; Ulger Z; Yavuz BB; Cankurtaran M; Cınar E; Arıoğul S Dement Geriatr Cogn Disord; 2012; 33(1):6-10. PubMed ID: 22354077 [TBL] [Abstract][Full Text] [Related]
5. Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome. Yilmaz MI; Sonmez A; Caglar K; Celik T; Yenicesu M; Eyileten T; Acikel C; Oguz Y; Yavuz I; Vural A Nephrology (Carlton); 2007 Apr; 12(2):147-53. PubMed ID: 17371337 [TBL] [Abstract][Full Text] [Related]
6. Risks of CHD identified by different criteria of metabolic syndrome and related changes of adipocytokines in elderly postmenopausal women. Ding QF; Hayashi T; Zhang XJ; Funami J; Ge L; Li J; Huang XL; Cao L; Zhang J; Akihisa I J Diabetes Complications; 2007; 21(5):315-9. PubMed ID: 17825756 [TBL] [Abstract][Full Text] [Related]
7. [Alzheimer disease--contribution of renin-angiotensin system to Alzheimer disease progression]. Ohrui T Nihon Rinsho; 2012 Sep; 70(9):1599-603. PubMed ID: 23012810 [TBL] [Abstract][Full Text] [Related]
8. Relationship between antihypertensive drug therapy and cognitive function in elderly hypertensive patients with memory complaints. Hanon O; Pequignot R; Seux ML; Lenoir H; Bune A; Rigaud AS; Forette F; Girerd X J Hypertens; 2006 Oct; 24(10):2101-7. PubMed ID: 16957572 [TBL] [Abstract][Full Text] [Related]
9. The renin-angiotensin system and antihypertensive drugs in Alzheimer's disease: current standing of the angiotensin hypothesis? Kehoe PG; Passmore PA J Alzheimers Dis; 2012; 30 Suppl 2():S251-68. PubMed ID: 22330821 [TBL] [Abstract][Full Text] [Related]
10. The association of renin-angiotensin system blockade use with the risks of cognitive impairment of aging and Alzheimer's disease: A meta-analysis. Zhuang S; Wang HF; Wang X; Li J; Xing CM J Clin Neurosci; 2016 Nov; 33():32-38. PubMed ID: 27475317 [TBL] [Abstract][Full Text] [Related]
11. Altered serum levels of adipokines and insulin in probable Alzheimer's disease. Khemka VK; Bagchi D; Bandyopadhyay K; Bir A; Chattopadhyay M; Biswas A; Basu D; Chakrabarti S J Alzheimers Dis; 2014; 41(2):525-33. PubMed ID: 24625795 [TBL] [Abstract][Full Text] [Related]
12. Effects of telmisartan on cognition and regional cerebral blood flow in hypertensive patients with Alzheimer's disease. Kume K; Hanyu H; Sakurai H; Takada Y; Onuma T; Iwamoto T Geriatr Gerontol Int; 2012 Apr; 12(2):207-14. PubMed ID: 21929736 [TBL] [Abstract][Full Text] [Related]
13. Suppressive effects of valsartan on microalbuminuria and CRP in patients with metabolic syndrome (Val-Mets). Shishido T; Konta T; Nishiyama S; Miyashita T; Miyamoto T; Takasaki S; Nitobe J; Watanabe T; Takeishi Y; Kubota I Clin Exp Hypertens; 2011; 33(2):117-23. PubMed ID: 21269062 [TBL] [Abstract][Full Text] [Related]
14. Treatment options and considerations for hypertensive patients to prevent dementia. Hernandorena I; Duron E; Vidal JS; Hanon O Expert Opin Pharmacother; 2017 Jul; 18(10):989-1000. PubMed ID: 28532183 [TBL] [Abstract][Full Text] [Related]
15. Renin-angiotensin blockade reduces serum free testosterone in middle-aged men on haemodialysis and correlates with erythropoietin resistance. DeLong M; Logan JL; Yong KC; Lien YH Nephrol Dial Transplant; 2005 Mar; 20(3):585-90. PubMed ID: 15735242 [TBL] [Abstract][Full Text] [Related]
16. Insulin resistance, inflammatory biomarkers, and adipokines in patients with chronic kidney disease: effects of angiotensin II blockade. de Vinuesa SG; Goicoechea M; Kanter J; Puerta M; Cachofeiro V; Lahera V; Gómez-Campderá F; Luño J J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S206-12. PubMed ID: 17130263 [TBL] [Abstract][Full Text] [Related]
19. Hypertension and the rate of cognitive decline in patients with dementia of the Alzheimer type. Bellew KM; Pigeon JG; Stang PE; Fleischman W; Gardner RM; Baker WW Alzheimer Dis Assoc Disord; 2004; 18(4):208-13. PubMed ID: 15592132 [TBL] [Abstract][Full Text] [Related]
20. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better? Weir MR Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]